Detalhe da pesquisa
1.
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Eur Radiol
; 31(2): 716-728, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852590